Atenolol Teaching 89
Instructed in new medication Atenolol to manage hypertension. In addition, warned of possible S/E such as fatigue, lethargy, vertigo, drowsiness, dizziness, fever, bradycardia, hypotension, heart failure, intermittent claudication, nausea, diarrhea, thrombocytopenia, hyperkalemia, hypoglycemia, increased risk of developing type-two diabetes, dyspnea, bronchospasm, rash and leg pain. Instructed to take drug exactly as prescribed at the same time every day. Do not stop drug suddenly but do call prescriber if unpleasant adverse reactions occur. If pulse rate is below 60 beats/minute, stop taking drug and call prescriber. Women: notify prescriber if pregnancy occurs. Drug usage might be discontinued.
Reviewed August 2018
Reviewed for general reference only. Adapt to your patient, agency policy, and scope of practice.
Related teachings
Atenolol Teaching 237Instructed patient about how Atenolol may mask symptoms of hypoglycemia in diabetic patients.Atenolol Teaching 238Instructed to patient to comply with diet, exercises and weight control in order to get the most benefit from the Atenolol.Atenolol Teaching 239Instructed patient that when using Atenolol he/she should be aware of symptoms of CHF and report inmediately if they appear, for example: difficulty breathing, specially when lying down, night cough, swelling of extremit...Atenolol Teaching 220Instructed patient about Atenolol and why it should be stored away from light, moisture and should be placed in a cool enviroment.